Edition:
United Kingdom

Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

180.00INR
18 Apr 2019
Change (% chg)

Rs-3.70 (-2.01%)
Prev Close
Rs183.70
Open
Rs184.10
Day's High
Rs184.65
Day's Low
Rs178.50
Volume
252,715
Avg. Vol
1,018,306
52-wk High
Rs438.00
52-wk Low
Rs140.70

Latest Key Developments (Source: Significant Developments)

Hitgen And Sparc Enter Dna-Encoded Library Based Innovative Drug Discovery Research Collaboration
Wednesday, 13 Mar 2019 

March 12 (Reuters) - :HITGEN AND SPARC ENTER DNA-ENCODED LIBRARY BASED INNOVATIVE DRUG DISCOVERY RESEARCH COLLABORATION.  Full Article

Sun Pharma Advanced Research Says Sun Pharma Global FZE Plans To Not Launch Elepsiatm XR
Friday, 15 Feb 2019 

Feb 15 (Reuters) - Sun Pharma Advanced Research Company Ltd ::SUN PHARMA ADVANCED RESEARCH COMPANY LTD - RECEIVED COMMUNICATION FROM SUN PHARMA GLOBAL FZE (SPGFZE), ABOUT PLANS TO NOT LAUNCH ELEPSIATM XR.SUN PHARMA ADVANCED RESEARCH COMPANY LTD - SPGFZE HAS DECIDED TO RETURN PRODUCT RIGHTS BACK TO CO.SUN PHARMA ADVANCED RESEARCH COMPANY LTD - CO WILL FIND ANOTHER PARTNER FOR COMMERCIALISING ELEPSIATM XR.  Full Article

Sun Pharma Advanced Research Gets Demand Notice For Assessment Yr 2014-15
Friday, 23 Feb 2018 

Feb 23 (Reuters) - Sun Pharma Advanced Research Company Ltd ::GOT DEMAND NOTICE' FOR PAYMENT OF A SUM OF 273 MILLION RUPEES FOR ASSESSMENT YEAR 2014-15.SAYS CO WOULD FILE APPROPRIATE APPEAL AGAINST INCOME TAX ORDER.  Full Article

India's Sun Pharma Advanced Research March-qtr loss widens
Friday, 5 May 2017 

May 5 (Reuters) - Sun Pharma Advanced Research Company Ltd :March quarter loss 322.7 million rupees.March quarter total revenue 453.4 million rupees.Says approved allotment of warrants worth inr 5 billion.Net loss in March quarter last year was 95.8 million rupees as per Ind-As; total revenue was 434.9 million rupees.  Full Article